tradingkey.logo

Dr Reddy's Laboratories Ltd

RDY
14.080USD
+0.120+0.86%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
11.72BCap. mercado
18.02P/E TTM

Dr Reddy's Laboratories Ltd

14.080
+0.120+0.86%

Más Datos de Dr Reddy's Laboratories Ltd Compañía

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Información de Dr Reddy's Laboratories Ltd

Símbolo de cotizaciónRDY
Nombre de la empresaDr Reddy's Laboratories Ltd
Fecha de salida a bolsaJan 01, 1986
Director ejecutivoAghanian (Patrick)
Número de empleados27811
Tipo de seguridadDepository Receipt
Fin del año fiscalJan 01
Dirección8-2-337, Road No.3 Banjara Hills
CiudadHYDERABAD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísIndia
Código postal500-034
Teléfono914049002900
Sitio Webhttps://www.drreddys.com/
Símbolo de cotizaciónRDY
Fecha de salida a bolsaJan 01, 1986
Director ejecutivoAghanian (Patrick)

Ejecutivos de Dr Reddy's Laboratories Ltd

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gunupati Venkateswa Prasad
Mr. Gunupati Venkateswa Prasad
Executive Co-Chairman, Managing Director
Executive Co-Chairman, Managing Director
--
--
Mr. Kallam Satish Reddy
Mr. Kallam Satish Reddy
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. M. V. Ramana
Mr. M. V. Ramana
Chief Executive Officer, Branded Markets (India and Emerging Markets)
Chief Executive Officer, Branded Markets (India and Emerging Markets)
--
--
Mr. Erez Israeli
Mr. Erez Israeli
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Shikha Sanjaya Sharma
Ms. Shikha Sanjaya Sharma
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Leo Puri
Mr. Leo Puri
Lead Non-Executive Independent Director
Lead Non-Executive Independent Director
--
--
Mr. Sanjay Sharma
Mr. Sanjay Sharma
Head - Global Operations
Head - Global Operations
--
--
Mr. Deepak Sapra
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Chief Executive Officer - API and Services
--
--
Mr. Patrick Aghanian
Mr. Patrick Aghanian
Chief Executive Officer, European Generics
Chief Executive Officer, European Generics
--
--
Kodumudi Pranatharthiharan Krishnan
Kodumudi Pranatharthiharan Krishnan
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gunupati Venkateswa Prasad
Mr. Gunupati Venkateswa Prasad
Executive Co-Chairman, Managing Director
Executive Co-Chairman, Managing Director
--
--
Mr. Kallam Satish Reddy
Mr. Kallam Satish Reddy
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. M. V. Ramana
Mr. M. V. Ramana
Chief Executive Officer, Branded Markets (India and Emerging Markets)
Chief Executive Officer, Branded Markets (India and Emerging Markets)
--
--
Mr. Erez Israeli
Mr. Erez Israeli
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Shikha Sanjaya Sharma
Ms. Shikha Sanjaya Sharma
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Leo Puri
Mr. Leo Puri
Lead Non-Executive Independent Director
Lead Non-Executive Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
382.89M
37.95%
Other
337.99M
33.50%
India
187.86M
18.62%
Russia
100.23M
9.93%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: sáb., 31 de ene
Actualizado: sáb., 31 de ene
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Robeco Institutional Asset Management B.V.
1.58%
Aperio Group, LLC
1.20%
RBC Global Asset Management (UK) Limited
1.17%
Renaissance Technologies LLC
1.05%
Aikya Investment Management Limited
0.88%
Otro
94.11%
Accionistas
Accionistas
Proporción
Robeco Institutional Asset Management B.V.
1.58%
Aperio Group, LLC
1.20%
RBC Global Asset Management (UK) Limited
1.17%
Renaissance Technologies LLC
1.05%
Aikya Investment Management Limited
0.88%
Otro
94.11%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
6.43%
Investment Advisor/Hedge Fund
4.37%
Hedge Fund
1.19%
Research Firm
1.12%
Pension Fund
0.35%
Family Office
0.20%
Bank and Trust
0.11%
Family Office
0.10%
Family Office
0.10%
Otro
86.01%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
528
115.10M
13.82%
-16.08M
2025Q3
516
112.51M
13.51%
-15.88M
2025Q2
504
118.15M
14.19%
-12.22M
2025Q1
506
114.84M
13.80%
-17.55M
2024Q4
478
124.61M
14.96%
-2.62M
2024Q3
462
118.95M
14.28%
-16.57M
2024Q2
445
126.18M
15.15%
-4.51M
2024Q1
437
124.83M
14.99%
-5.58M
2023Q4
427
125.49M
15.07%
-4.37M
2023Q3
406
119.09M
14.31%
-4.07M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Robeco Institutional Asset Management B.V.
13.08M
1.57%
+921.08K
+7.57%
Sep 30, 2025
Aperio Group, LLC
10.01M
1.2%
+745.22K
+8.05%
Sep 30, 2025
RBC Global Asset Management (UK) Limited
9.73M
1.17%
+402.24K
+4.31%
Sep 30, 2025
Renaissance Technologies LLC
8.78M
1.05%
-230.50K
-2.56%
Sep 30, 2025
Aikya Investment Management Limited
6.72M
0.81%
+360.03K
+5.67%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
5.35M
0.64%
-47.64K
-0.88%
Sep 30, 2025
The Vanguard Group, Inc.
5.11M
0.61%
+135.96K
+2.73%
Sep 30, 2025
Parametric Portfolio Associates LLC
4.46M
0.54%
+188.22K
+4.40%
Sep 30, 2025
State Street Investment Management (US)
4.16M
0.5%
-33.90K
-0.81%
Sep 30, 2025
BNP Paribas Securities Corp. North America
4.00M
0.48%
-10.71K
-0.27%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
National Security Emerging Markets Index ETF
0.91%
Invesco S&P Emerging Markets Low Volatility ETF
0.39%
Lattice Hartford Multifactor Emerging Markets ETF
0.33%
DFA Dimensional Emerging Markets Value ETF
0.22%
ActivePassive International Equity ETF
0.18%
SPDR MSCI Emerging Markets StrategicFactors ETF
0.15%
DFA Dimensional Emerging Mkts High Proftblty ETF
0.13%
SPDR Portfolio Emerging Markets ETF
0.12%
Avantis Emerging Markets Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.12%
Ver más
National Security Emerging Markets Index ETF
Proporción0.91%
Invesco S&P Emerging Markets Low Volatility ETF
Proporción0.39%
Lattice Hartford Multifactor Emerging Markets ETF
Proporción0.33%
DFA Dimensional Emerging Markets Value ETF
Proporción0.22%
ActivePassive International Equity ETF
Proporción0.18%
SPDR MSCI Emerging Markets StrategicFactors ETF
Proporción0.15%
DFA Dimensional Emerging Mkts High Proftblty ETF
Proporción0.13%
SPDR Portfolio Emerging Markets ETF
Proporción0.12%
Avantis Emerging Markets Equity ETF
Proporción0.12%
SP Funds S&P World (ex-US) ETF
Proporción0.12%

Dividendos

Un total de 332.70M USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
May 09, 2024
RDY.NB Final Cash Dividend of gross USD 0.476153 paid on Aug 12, 2024 going ex on Jul 30, 2024
Jul 15, 2024
Aug 12, 2024
Jul 30, 2024
May 11, 2023
RDY.NB Final Cash Dividend of gross USD 0.482608 paid on Aug 11, 2023 going ex on Jul 28, 2023
Jul 10, 2023
Aug 11, 2023
Jul 28, 2023
May 24, 2022
RDY.NB Final Cash Dividend of gross USD 0.378434 paid on Aug 12, 2022 going ex on Aug 01, 2022
Jul 11, 2022
Aug 12, 2022
Aug 01, 2022
Jun 16, 2021
RDY.NB Final Cash Dividend of gross USD 0.336485 paid on Aug 11, 2021 going ex on Jul 30, 2021
Jul 09, 2021
Aug 11, 2021
Jul 30, 2021
Jun 26, 2020
RDY.NB Final Cash Dividend of gross USD 0.333364 paid on Aug 17, 2020 going ex on Jul 10, 2020
Jul 13, 2020
Aug 17, 2020
Jul 10, 2020

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Oct 07, 2024
Split
1→5
Fecha
Fecha ex-dividendo
Tipo
Relación
Oct 07, 2024
Split
1→5
KeyAI